Comparison Chart for PE Treatments

PRΩLONG™ unveiled at the World Meeting of Sexual Medicine in Chicago in August 2012. Read more…

Too busy to read reams of information? Here’s a simple chart to help you compare premature ejaculation treatment options, including costs and possible side effects.

  PRΩLONG™ Climax Control Programme LOCAL ANAESTHETIC PSYCHOSEXUAL THERAPY DAPOXETINE (PRILIGY)
Cost of the treatment per week €33 per week for 6 weeks only (device and Start-Stop technique 6 week training programme) Around €2-15 per week for life €100-150 per session for 4-6 sessions of Behaviour Therapy programme with Start-Stop technique €210-280 per week if used daily (€30-40 per pill) for life
Effect Effect starts from week 1, maximum at week 6 On demand effect, after 5-10 minutes of using spray or cream Effect at week 4-6 Same day effect
How long does the effect of the treatment last At least 3 months after stopping programme (clinical studies did not extend beyond 3 months)
(Ref 2,3)		 Stopping the use of the local anaesthetic agent will result in the problem returning At least 3 months (same clinical trial comparing therapy to PRΩLONG™ prototype)
(Ref 2,3)		 Stopping the drug will result in the problem returning
Side Effects None Possible skin irritation. Numbness of sexual sensation both to man and woman if no condom is used. Loss of erection was found in 16 out of 40 men in a study.
(Ref 4)		 None Common Side Effects: dry mouth, stomach pain, anxiety or restlessness, weakness, clenching teeth, fatigue, tremors, sweating, bloating, stuffy nose
Effectiveness 11 fold
improvement during intercourse in 61% of men, to an average of 9 minutes from less than 1 minute before treatment
(Ref 2,3)		 3-6 fold
improvement in 20% of men, to 4 minutes from less than 1 minute before treatment
(Ref 5)		 3.5 fold
improvement in 40% of men, to almost 3 minutes from less than 1 minute before treatment.
(Ref 2,3)		 3 fold
improvement in 58.4% of men, to almost 3 minutes from less than 1 minute before treatment
(Ref 7)
Access No prescription needed. Internet or over the counter purchase. No prescription needed. Internet or over the counter purchase. Specially trained sexual therapist Doctor / Nurse prescription
Alcohol No interaction No interaction No interaction Must not use alcohol with the drug, due to interactions and side effects.
Does your partner need to know? No.
The device is not used during intercourse but for training on your own 3 times per week, for a total of 6 weeks.		 Yes.
You must inform your partner in case he/she is allergic to local anaesthetics.		 Yes.
This is due to the fact that going to therapy with a partner gives better results.		 No.
The drug can be used without the partner knowing.

PRΩLONG™ Climax Control Programme is recommended as a first line treatment for premature ejaculation (PE). (Ref 8,9,10,11)

References: Clinical trials and scientific data

A) PRΩLONG™ Climax Control Programme (Prototype Device + Start-Stop Technique):

1. Wise ME and Watson JP: ‘A new treatment for premature ejaculation: a case series for a desensitising ring.’ Sexual and Relationship Therapy. 15(4): 345-50, 2000.

2. Wise M E J, Pujol M, Baggaley M, Crowe M: ‘A novel treatment for premature ejaculation: a randomised controlled trial.’ Poster presentation, Royal College of Psychiatrists Annual Conference 2004 and American Psychiatric Association Annual Conference, Washington DC 2004.

3. Zamar A: ‘Premature Ejaculation: A new treatment using a stimulating device in conjunction with the Start-Stop technique.’ Abstract: A-354-0008-01237: Symposium, 20th World Congress for Sexual Health, Glasgow 2011.

8. Zamar A.C: (2011). Desensitizing Apparatus, World Intellectual Property organisation, European Patent Office, Geneva, PCT/GB2011/050847, April 28.

9. Zamar A: ‘Premature ejaculation: A new treatment using a stimulating device in conjunction with the start-stop technique.’ World Meeting on Sexual Medicine, Chicago 2012.

10. Zamar A: ‘Premature ejaculation: A new treatment using a stimulating device in conjunction with the start-stop technique.’ Proceedings of the World Meeting on Sexual Medicine, J Sex Med 2012: 9 (suppl4): 183-298

11. Zamar A: ‘Prolong (TM): review of a newly approved treatment for premature ejaculation in Europe.’ European Society for Sexual Medicine (ESSM ) conference, Amsterdam 2012.

B) Local Anaesthetics:

4. Atikeler MK, Gecit I, Senol FA: ‘Optimum usage of prilocaine-lidocaine cream in premature ejaculation.’ Androlog 2002; 34: 356–9* (study referred to in side effects of local anaesthetics)

5. Henry R, Morales A: ‘Topical lidocaine- prilocaine spray for the treatment of premature ejaculation: a proof of concept study.’ Int J Imp Res 2003; 15:277–81

C) Psychosexual Therapy (Cognitive Behavioural Therapy + Start-Stop Technique):

6. Wise M E J, Pujol M, Baggaley M, Crowe M: ‘A novel treatment for premature ejaculation: a randomised controlled trial.’ Poster presentation, Royal College of Psychiatrists Annual Conference, Harrogate UK 2004 and American Psychiatric Association Annual Conference, Washington DC 2004.

D) Dapoxetine (Priligy):

7. A M Feige, M R Pinsky, W J G Hellstrom: ‘Dapoxetine for Premature Ejaculation.’ Clinical Pharmacology & Therapeutics (2011) 89 1, 125–128.